FindTrial
Sign In

Identifying homeopathy medicines in use for protection against COVID-19, calculating the number of COVID-19 cases or cases with COVID-19 like symptoms in these homeopathy users and identifying some general features like age, gender and location in them.

Understanding usage of homeopathy medicines for prophylaxis against COVID-19 and estimation of the incidence of COVID-19 or COVID-19 like symptoms in the cohort of homeopathic users

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027560
Enrollment
6500
Registered
2020-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Kalyan Banerjee Dr Kushal Banerjee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals of all ages and both genders who have taken homeopathic medicines for prophylaxis against COVID-19

Exclusion criteria

Exclusion criteria: Individuals who have not taken any homeoapthic medicines for prophyalxis against COVID-19

Design outcomes

Primary

MeasureTime frame
Laboratory confirmation of COVID19 or COVID19 like symptomsTimepoint: Baseline—

Secondary

MeasureTime frame
Demographic DetailsTimepoint: Baseline—

Countries

Australia, Belgium, Canada, China, Germany, Hong Kong, India, Italy, Norway, Singapore, Sweden, Switzerland, Thailand, United Arab Emirates, United Kingdom, United States of America

Contacts

Public ContactKushal Banerjee

Dr. Kalyan Banerjees Clinic

kushal@drkbanerjee.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026